PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP.

Similar documents
PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

PRESCRIBING INFORMATION ISOPTO ATROPINE. Atropine Sulfate Ophthalmic Solution, BP. 1% w/v. Sterile. Cycloplegic - Mydriatic

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

PRODUCT INFORMATION ALCAINE. Proparacaine Hydrochloride Sterile Ophthalmic Solution, USP. 5 mg/ml. Topical Anesthetic

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

CYCLOGYL * PRESCRIBING INFORMATION. Cyclopentolate Hydrochloride Ophthalmic Solution, USP. 1% w/v. Sterile. Anticholinergic

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

CONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative

PRESCRIBING INFORMATION

ISOPTO CARPINE Eye Drops

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed.

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

Dorzolamide 20 mg/ml Eye Drops, Solution

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

PATIENT INFORMATION LEAFLET

ACULAR EYE DROPS 5 mg/ml Eye Drops

NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.

PATIENT INFORMATION LEAFLET

3 DOSAGE FORMS AND STRENGTHS

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide

PRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard

This leaflet's format was set and its contents inspected and approved by the Ministry of Health

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

IMPORTANT: PLEASE READ

CONTRAINDICATIONS None.

TIMALEN 0.5% eye drops

IMPORTANT: PLEASE READ

ZADITEN Eye Drops 1.0%

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

PRODUCT MONOGRAPH TARCEVA. erlotinib hydrochloride tablets. erlotinib 25, 100, 150 mg

PATIENT MEDICATION INFORMATION

ONBREZ BREEZHALER should only be used to treat COPD.

MAXITROL Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

APO-Latanoprost Contains the active ingredient latanoprost

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0.

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

NEVANAC TM 0.1% Eye Drops

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

PRESCRIBING INFORMATION MYDFRIN * Phenylephrine Hydrochloride Ophthalmic Solution. Vasoconstrictor and Mydriatic for Use in Ophthalmology

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

IMPORTANT: PLEASE READ

VOLTAREN OPHTHA Eye Drops 0.1%

Package leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

OXEZE TURBUHALER formoterol fumarate dihydrate

ALCAINE Eye Drops contain proxymetacaine hydrochloride. The chemical structure of proxymetacaine hydrochloride is:

PATIENT INFORMATION LEAFLET

IMPORTANT: PLEASE READ

MAXIDEX Eye Drops 0.1%

CILOXAN TM Eye Drops 0.3%

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

IMPORTANT: PLEASE READ

BrinzoQuin Eye Drops 1.0%

Chemical Name: 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt.

PRODUCT INFORMATION NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY. PATANOL * (Olopatadine) 0.1 % Eye Drops

What Maxitrol Eye Drops is used for

IMPORTANT: PLEASE READ

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

ENIDIN EYE DROPS [brimonidine tartrate]

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION. ixekizumab

IMPORTANT: PLEASE READ

EXELON should only be used if prescribed to you by your doctor. EXELON contains the active substance rivastigmine hydrogen tartrate.

Mydrilate eye drops are applied on the surface of the eyes for diagnostic purposes during eye examinations and refraction tests.

HIGHLIGHTS OF PRESCRIBING INFORMATION

Package leaflet: Information for the user. Carmellose sodium

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (omeprazole delayed release capsules USP)

TOBRADEX TM Eye Drops

YOUR VYZULTA TREATMENT GUIDE. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information.

Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Sterile) Rx only

Package leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS. Betaxolol (as hydrochloride)

PRESCRIBING INFORMATION with the Consumer Information FLUORESCITE* fluorescein injection, USP. fluorescein 10% w/v (as fluorescein sodium) Sterile

Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5%

PRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)

Transcription:

PRESCRIBING INFORMATION AND CONSUMER INFORMATION Pr ISOPTO * CARPINE pilocarpine hydrochloride ophthalmic solution, USP 1%, 2% and 4% w/v Parasympathomimetic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca Date of Preparation: January 25, 2016 Submission Control No: 185389 * a trademark of Novartis 131-ISOPTO CARPINE Prescribing Information non-annotated Page 1 of 12

Table of Contents HEALTH PROFESSIONAL INFORMATION...3 SUMMARY PRODUCT INFORMATION...3 INDICATIONS AND CLINICAL USE...3 CONTRAINDICATIONS...3 WARNINGS AND PRECAUTIONS...3 ADVERSE REACTIONS...5 DRUG INTERACTIONS...5 DOSAGE AND ADMINISTRATION...5 OVERDOSAGE...5 STORAGE AND STABILITY...6 DOSAGE FORMS, COMPOSITION AND PACKAGING...6 CONSUMER INFORMATION...7 CONSUMER INFORMATION...9 CONSUMER INFORMATION...11 131-ISOPTO CARPINE Prescribing Information non-annotated Page 2 of 12

Pr ISOPTO * CARPINE pilocarpine hydrochloride ophthalmic solution, USP HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Topical (ophthalmic) Solution/ Pilocarpine hydrochloride 1, 2 and 4% w/v Clinically Relevant Nonmedicinal Ingredients Benzalkonium chloride as preservative. For a complete listing see Dosage Forms, Composition and Packaging section. INDICATIONS AND CLINICAL USE ISOPTO * CARPINE (pilocarpine hydrochloride ophthalmic solution, USP) is indicated for the reduction of intraocular pressure. Geriatrics (> 65 years of age): Elderly patients may be at a higher risk for pilocarpine-induced mental status changes, including psychosis and dementia of the Alzheimer type. CONTRAINDICATIONS ISOPTO * CARPINE is contraindicated in: Patients who are hypersensitive to this drug or to any ingredient in the formulation or component of the container. For a complete listing, see the Dosage Forms, Composition and Packaging section of the Prescribing Information. Conditions where pupillary constriction is undesirable, such as acute iritis or anterior uveitis. WARNINGS AND PRECAUTIONS General ISOPTO * CARPINE should be used with caution in patients with acute cardiac failure, bronchial asthma, peptic ulcer, hyperthyroidism, gastro-intestinal spasm, Parkinson s disease, urinary tract obstruction, recent myocardial infarction, hypertension and hypotension due to the risk of exacerbating these conditions. 131-ISOPTO CARPINE Prescribing Information non-annotated Page 3 of 12

Nasolacrimal occlusion or gently closing the eyelid after administration is recommended. This may reduce the systemic absorption of medicinal ingredients administered via the ocular route and result in a decrease in systemic adverse reactions. ISOPTO * CARPINE has a major influence on the ability to drive and use machines. Miosis may cause blurred vision and difficulty in dark adaptation. Patients should be advised to exercise caution while driving at night or while performing hazardous tasks in poor light. Ophthalmologic Retinal detachment has been reported when miotics are used in susceptible individuals, such as young patients with myopia or patients with a history of retinal detachment. Fundus examination is advised prior to initiation of treatment with ISOPTO * CARPINE. Miotics should be avoided in acute inflammatory diseases of the anterior chamber. A paradoxical rise in intraocular pressure may be observed in patients with severely compromised trabecular outflow. Caution is advised in the presence of corneal or conjunctival damage to avoid excessive penetration, which can produce systemic toxicity. ISOPTO * CARPINE contains the preservative benzalkonium chloride, which may cause eye irritation and is known to discolour soft contact lenses. Avoid contact with soft contact lenses. Patients must be instructed to remove contact lenses prior to the application of ISOPTO * CARPINE and wait at least 15 minutes before reinsertion. Sexual Function/Reproduction Studies have not been performed to evaluate the effect of topical ocular administration of ISOPTO * CARPINE on fertility. Special Populations Pregnant Women: There are no or limited amount of data from the use of ISOPTO * CARPINE in pregnant women. Animal studies have, however, showed harmful effects of systemic pilocarpine exposure with respect to reproductive toxicity in rats. ISOPTO * CARPINE should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. Nursing Women: It is unknown whether pilocarpine is excreted in human milk. Because many drugs are excreted in breast milk, caution should be exercised when administering ISOPTO * CARPINE to a nursing woman. Geriatrics (> 65 years of age): Elderly patients may be at a higher risk for pilocarpine-induced mental status changes, including psychosis and dementia of the Alzheimer type. 131-ISOPTO CARPINE Prescribing Information non-annotated Page 4 of 12

ADVERSE REACTIONS The following adverse reactions that have been reported during clinical trials with ISOPTO * CARPINE: Eye disorders: Very common: vision blurred; Common: eye irritation, eye pain, ocular hyperemia, photopsia, visual acuity reduced, vitreous floaters; Uncommon: eyelid edema, foreign body sensation in eyes, glare, miosis, retinal tear, vitreous detachment, vitreous hemorrhage; Gastrointestinal disorders: Common: nausea; Nervous system disorders: Very common: headache; common: dizziness. Additional adverse reactions identified from post-marketing surveillance include the following: Eye disorders: corneal edema, intraocular pressure increased; Gastrointestinal disorders: vomiting. DRUG INTERACTIONS No clinically relevant interactions have been described. DOSAGE AND ADMINISTRATION Recommended Dose Instill 2 drops topically in the affected eye(s) 3 or 4 times daily. Administration Nasolacrimal occlusion or gently closing the eyelid after administration is recommended (see WARNINGS AND PRECAUTIONS, General). To prevent contamination of the solution, care must be taken to avoid touching the dropper tip to any surface. OVERDOSAGE In case of overdose, symptoms of toxicity may include: headache, salivation, sweating, syncope, bradycardia, hypotension, abdominal cramps, vomiting, asthma and diarrhea. Treatment of overdose should be supportive. In cases of severe systemic toxicity, therapy with anticholinergics may be necessary. For management of a suspected drug overdose, contact your regional Poison Control Centre. 131-ISOPTO CARPINE Prescribing Information non-annotated Page 5 of 12

STORAGE AND STABILITY Store at room temperature. Avoid excessive heat. Keep bottle tightly closed when not in use. Keep out of the reach and sight of children. DOSAGE FORMS, COMPOSITION AND PACKAGING ISOPTO * CARPINE is a sterile ophthalmic solution and is available in three strengths (1%, 2% and 4%). ISOPTO * CARPINE 1%: Each ml of ISOPTO * CARPINE 1% contains: Active: pilocarpine hydrochloride 1% w/v Preservative: benzalkonium chloride 0.01% w/v Inactives: boric acid, hydroxypropyl methylcellulose, sodium chloride, sodium citrate, sodium hydroxide and/or hydrochloric acid (to adjust ph) and purified water. ISOPTO * CARPINE 2%: Each ml of ISOPTO * CARPINE 2% contains: Active: pilocarpine hydrochloride 2% w/v Preservative: benzalkonium chloride 0.01% w/v Inactives: boric acid, hydroxypropyl methylcellulose, sodium citrate, sodium hydroxide and/or hydrochloric acid (to adjust ph) and purified water. ISOPTO * CARPINE 4%: Each ml of ISOPTO * CARPINE 4% contains: Active: pilocarpine hydrochloride 4% w/v Preservative: benzalkonium chloride 0.01% w/v Inactives: boric acid, hydroxypropyl methylcellulose, sodium citrate, sodium hydroxide and/or hydrochloric acid (to adjust ph) and purified water. ISOPTO * CARPINE is supplied in 15 ml DROPTAINER * dispensers. Tamper evidence is provided by a closure with an extended skirt that locks to the bottle finish on application and breaks away from the closure on opening. After cap is removed: if the tamper evident snap collar is loose, remove collar before using product. 131-ISOPTO CARPINE Prescribing Information non-annotated Page 6 of 12

IMPORTANT: PLEASE READ CONSUMER INFORMATION Pr ISOPTO * CARPINE Pilocarpine Hydrochloride Ophthalmic Solution, USP 1% w/v This leaflet is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about ISOPTO * CARPINE. Contact your doctor or pharmacist if you have any questions about the drug. ABOUT THIS MEDICATION What the medication is used for: ISOPTO * CARPINE is used to lower the pressure in your eye (intraocular pressure). What it does: ISOPTO * CARPINE contains pilocarpine hydrochloride, which works to lower intraocular pressure by increasing the amount of fluid draining inside the eye. When it should not be used: Do not use ISOPTO * CARPINE if you: Are allergic (hypersensitive) to pilocarpine or any other of the ingredients in ISOPTO * CARPINE (see What the important nonmedicinal ingredients are). Have inflammation of the coloured parts of the eye (uvea or iris). What the medicinal ingredient is: Pilocarpine hydrochloride 1% w/v What the important nonmedicinal ingredients are: Preservative: benzalkonium chloride Others: boric acid, hydroxypropyl methylcellulose, sodium chloride, sodium citrate, sodium hydroxide and/or hydrochloric acid (to adjust ph), and purified water. Are elderly. You may be at a higher risk for changes in mental function (e.g. dementia, psychosis) Contact Lens Wearers ISOPTO * CARPINE contains a preservative, benzalkonium chloride, which is known to affect soft contact lenses. Remove your contact lenses before using ISOPTO * CARPINE and wait at least 15 minutes before putting your lenses back in. Driving and Using Machines ISOPTO * CARPINE may cause blurred vision and sensitivity to light and can affect your ability to drive and use machines, especially at night and in low lighting. Do not drive or use machines until your vision clears. Pregnancy and Breastfeeding If you are pregnant, may be pregnant, are breastfeeding or planning to breastfeed, ask your doctor for advice. INTERACTIONS WITH THIS MEDICATION Tell your doctor or pharmacist about all the medicines you take, recently took or are planning to take, including those without a prescription. Drug interaction studies have not been done for ISOPTO * CARPINE. PROPER USE OF THIS MEDICATION Usual adult dose: Apply 2 drops in the affected eye(s) 3 or 4 times a day or as directed by your doctor. How to use: What dosage forms it comes in: ISOPTO* CARPINE is an eye drop solution. WARNINGS AND PRECAUTIONS BEFORE you use ISOPTO * CARPINE talk to your doctor or pharmacist if you have: Ever had a detached retina or are young and near-sighted. You may be at a greater risk of a retinal detachment. Eye inflammation of the surface of your eye. Any damage to the eye. Problems with the drainage of liquid inside the eye. Heart disease, heart problems or a recent heart attack. Low or high blood pressure. Asthma. Difficulty in urinating (e.g. urinary obstruction). Stomach ulcers. An overactive thyroid (hyperthyroidism). Stomach spasms. Parkinson s disease. 1 2 3 Get the ISOPTO * CARPINE bottle and a mirror. Wash your hands. Twist off the bottle cap. After cap is removed: if security collar is loose, remove before using product. Hold the bottle, pointing down, between your thumb and fingers. Tilt your head back. Pull down your lower eyelid with a clean finger until there is a pocket between the eyelid and your eye. The drop will go in here (picture 1). Bring the bottle tip close to the eye. Do this in front of a mirror if it helps. Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops. 131-ISOPTO CARPINE Prescribing Information non-annotated Page 7 of 12

IMPORTANT: PLEASE READ Gently press on the base of the bottle to release one drop of ISOPTO * CARPINE at a time. Do not squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs (picture 2). After using ISOPTO * CARPINE, press a finger into the corner of your eye, by the nose (picture 3). This helps to stop ISOPTO * CARPINE getting into the rest of the body. If a drop misses your eye, try again. If you use drops in both eyes, repeat the steps for your other eye. Close the bottle cap firmly immediately after use. Wash your hands after use. If you are using other eye medicines, wait at least 5-10 minutes between applying ISOPTO * CARPINE and the other drops. Eye ointments should be applied last. Overdose: If you use more ISOPTO * CARPINE than you should, rinse it all out with warm water. Do not put in any more drops until it is time for you next regular dose. Symptoms of an overdose may include: headache, salivating, sweating, fainting, slow heart rate, low blood pressure, stomach cramps, vomiting, asthma or diarrhea. In severe cases of an overdose, a doctor may need to treat you with another drug known as an anticholinergic. In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms. Missed Dose: If you forget to use ISOPTO * CARPINE, use a single dose as soon as you remember. If it is almost time for the next dose, leave out the missed dose and continue with the next dose of your regular routine. Do not use a double dose to make up for a missed dose. SIDE EFFECTS AND WHAT TO DO ABOUT THEM Like all medicines, ISOPTO * CARPINE may cause side effects, although not everybody gets them. closed when not in use. Keep out of the reach and sight of children. REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways: -------------------------------------------------------------------------- $ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345 $ Complete a Canada Vigilance Reporting Form and: - Fax toll-free to 1-866-678-6789, or - Mail to: Canada Vigilance Program Health Canada Postal Locator 0701D Ottawa, Ontario K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect Canada Web site at www.healthcanada.gc.ca/medeffect. NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice. MORE INFORMATION This document plus the full Prescribing Information, prepared for health professionals can be found at: http://www.alcon.ca or by contacting the sponsor, Alcon Canada Inc. at: 1-800-613-2245 This leaflet was prepared by Alcon Canada Inc. Last revised: January 25, 2016 2015 Novartis * a trademark of Novartis Side effects seen with ISOPTO * CARPINE include: blurred, reduced or abnormal vision, eye pain, eye irritation, eye redness, spots in your field of vision, retinal tear, bleeding inside the eye, eyelid swelling, decrease in pupil size, glare, abnormal sensation in the eye, increased eye pressure, eye swelling, headache, dizziness, nausea, and vomiting. This is not a complete list of side effects. For any unexpected effects while taking ISOPTO* CARPINE, contact your doctor or pharmacist. HOW TO STORE IT Store at room temperature. Avoid excessive heat. Keep tightly 131-ISOPTO CARPINE Prescribing Information non- annotated Page 8 of 12

IMPORTANT: PLEASE READ CONSUMER INFORMATION Pr ISOPTO * CARPINE Pilocarpine Hydrochloride Ophthalmic Solution, USP 2% w/v This leaflet is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about ISOPTO * CARPINE. Contact your doctor or pharmacist if you have any questions about the drug. ABOUT THIS MEDICATION What the medication is used for: ISOPTO * CARPINE is used to lower the pressure in your eye (intraocular pressure). What it does: ISOPTO * CARPINE contains pilocarpine hydrochloride, which works to lower intraocular pressure by increasing the amount of fluid draining inside the eye. When it should not be used: Do not use ISOPTO * CARPINE if you: Are allergic (hypersensitive) to pilocarpine or any other of the ingredients in ISOPTO * CARPINE (see What the important nonmedicinal ingredients are). Have inflammation of the coloured parts of the eye (uvea or iris). What the medicinal ingredient is: Pilocarpine hydrochloride 2% w/v What the important nonmedicinal ingredients are: Preservative: benzalkonium chloride Others: boric acid, hydroxypropyl methylcellulose, sodium citrate, sodium hydroxide and/or hydrochloric acid (to adjust ph), and purified water. Are elderly. You may be at a higher risk for changes in mental function (e.g. dementia, psychosis). Contact Lens Wearers ISOPTO * CARPINE contains a preservative, benzalkonium chloride, which is known to affect soft contact lenses. Remove your contact lenses before using ISOPTO * CARPINE and wait at least 15 minutes before putting your lenses back in. Driving and Using Machines ISOPTO * CARPINE may cause blurred vision and sensitivity to light and can affect your ability to drive and use machines, especially at night and in low lighting. Do not drive or use machines until your vision clears. Pregnancy and Breastfeeding If you are pregnant, may be pregnant, are breastfeeding or planning to breastfeed, ask your doctor for advice. INTERACTIONS WITH THIS MEDICATION Tell your doctor or pharmacist about all the medicines you take, recently took or are planning to take, including those without a prescription. Drug interaction studies have not been done for ISOPTO * CARPINE. PROPER USE OF THIS MEDICATION Usual adult dose: Apply 2 drops in the affected eye(s) 3 or 4 times a day or as directed by your doctor. How to use: What dosage forms it comes in: ISOPTO * CARPINE is an eye drop solution. WARNINGS AND PRECAUTIONS BEFORE you use ISOPTO * CARPINE talk to your doctor or pharmacist if you have: Ever had a detached retina or are young and near-sighted. You may be at a greater risk of a retinal detachment. Eye inflammation of the surface of your eye. Any damage to the eye. Problems with the drainage of liquid inside the eye. Heart disease, heart problems or a recent heart attack. Low or high blood pressure. Asthma. Difficulty in urinating (e.g. urinary obstruction). Stomach ulcers. An overactive thyroid (hyperthyroidism). Stomach spasms. Parkinson s disease. 1 2 3 Get the ISOPTO * CARPINE bottle and a mirror. Wash your hands. Twist off the bottle cap. After cap is removed: if security collar is loose, remove before using product. Hold the bottle, pointing down, between your thumb and fingers. Tilt your head back. Pull down your lower eyelid with a clean finger until there is a pocket between the eyelid and your eye. The drop will go in here (picture 1). Bring the bottle tip close to the eye. Do this in front of a mirror if it helps. Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops. 131-ISOPTO CARPINE Prescribing Information non-annotated Page 9 of 12

IMPORTANT: PLEASE READ Gently press on the base of the bottle to release one drop of ISOPTO * CARPINE at a time. Do not squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs (picture 2). After using ISOPTO * CARPINE, press a finger into the corner of your eye, by the nose (picture 3). This helps to stop ISOPTO * CARPINE getting into the rest of the body. If a drop misses your eye, try again. If you use drops in both eyes, repeat the steps for your other eye. Close the bottle cap firmly immediately after use. Wash your hands after use. If you are using other eye medicines, wait at least 5-10 minutes between applying ISOPTO * CARPINE and the other drops. Eye ointments should be applied last. Overdose: If you use more ISOPTO * CARPINE than you should, rinse it all out with warm water. Do not put in any more drops until it is time for you next regular dose. Symptoms of an overdose may include: headache, salivating, sweating, fainting, slow heart rate, low blood pressure, stomach cramps, vomiting, asthma or diarrhea. In severe cases of an overdose, a doctor may need to treat you with another drug known as an anticholinergic. In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms. Missed Dose: If you forget to use ISOPTO * CARPINE, use a single dose as soon as you remember. If it is almost time for the next dose, leave out the missed dose and continue with the next dose of your regular routine. Do not use a double dose to make up for a missed dose. SIDE EFFECTS AND WHAT TO DO ABOUT THEM Like all medicines, ISOPTO * CARPINE may cause side effects, although not everybody gets them. closed when not in use. Keep out of the reach and sight of children. REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways: -------------------------------------------------------------------------- $ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345 $ Complete a Canada Vigilance Reporting Form and: - Fax toll-free to 1-866-678-6789, or - Mail to: Canada Vigilance Program Health Canada Postal Locator 0701D Ottawa, Ontario K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect Canada Web site at www.healthcanada.gc.ca/medeffect. NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice. MORE INFORMATION This document plus the full Prescribing Information, prepared for health professionals can be found at: http://www.alcon.ca or by contacting the sponsor, Alcon Canada Inc. at: 1-800-613-2245 This leaflet was prepared by Alcon Canada Inc. Last revised: January 25, 2016 2015 Novartis * a trademark of Novartis Side effects seen with ISOPTO * CARPINE include: blurred, reduced or abnormal vision, eye pain, eye irritation, eye redness, spots in your field of vision, retinal tear, bleeding inside the eye, eyelid swelling, decrease in pupil size, glare, abnormal sensation in the eye, increased eye pressure, eye swelling, headache, dizziness, nausea, and vomiting. This is not a complete list of side effects. For any unexpected effects while taking ISOPTO * CARPINE, contact your doctor or pharmacist. HOW TO STORE IT Store at room temperature. Avoid excessive heat. Keep tightly 131-ISOPTO CARPINE Prescribing Information non- annotated Page 10 of 12

IMPORTANT: PLEASE READ CONSUMER INFORMATION Pr ISOPTO * CARPINE Pilocarpine Hydrochloride Ophthalmic Solution, USP 4% w/v This leaflet is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about ISOPTO * CARPINE. Contact your doctor or pharmacist if you have any questions about the drug. ABOUT THIS MEDICATION What the medication is used for: ISOPTO * CARPINE is used to lower the pressure in your eye (intraocular pressure). What it does: ISOPTO * CARPINE contains pilocarpine hydrochloride, which works to lower intraocular pressure by increasing the amount of fluid draining inside the eye. When it should not be used: Do not use ISOPTO * CARPINE if you: Are allergic (hypersensitive) to pilocarpine or any other of the ingredients in ISOPTO * CARPINE (see What the important nonmedicinal ingredients are). Have inflammation of the coloured parts of the eye (uvea or iris). What the medicinal ingredient is: Pilocarpine hydrochloride 2% w/v What the important nonmedicinal ingredients are: Preservative: benzalkonium chloride Others: boric acid, hydroxypropyl methylcellulose, sodium citrate, sodium hydroxide and/or hydrochloric acid (to adjust ph), and purified water. Are elderly. You may be at a higher risk for changes in mental function (e.g. dementia, psychosis). Contact Lens Wearers ISOPTO * CARPINE contains a preservative, benzalkonium chloride, which is known to affect soft contact lenses. Remove your contact lenses before using ISOPTO * CARPINE and wait at least 15 minutes before putting your lenses back in. Driving and Using Machines ISOPTO * CARPINE may cause blurred vision and sensitivity to light and can affect your ability to drive and use machines, especially at night and in low lighting. Do not drive or use machines until your vision clears. Pregnancy and Breastfeeding If you are pregnant, may be pregnant, are breastfeeding or planning to breastfeed, ask your doctor for advice. INTERACTIONS WITH THIS MEDICATION Tell your doctor or pharmacist about all the medicines you take, recently took or are planning to take, including those without a prescription. Drug interaction studies have not been done for ISOPTO * CARPINE. PROPER USE OF THIS MEDICATION Usual adult dose: Apply 2 drops in the affected eye(s) 3 or 4 times a day or as directed by your doctor. How to use: What dosage forms it comes in: ISOPTO * CARPINE is an eye drop solution. WARNINGS AND PRECAUTIONS BEFORE you use ISOPTO * CARPINE talk to your doctor or pharmacist if you have: Ever had a detached retina or are young and near-sighted. You may be at a greater risk of a retinal detachment. Eye inflammation of the surface of your eye. Any damage to the eye. Problems with the drainage of liquid inside the eye. Heart disease, heart problems or a recent heart attack. Low or high blood pressure. Asthma. Difficulty in urinating (e.g. urinary obstruction). Stomach ulcers. An overactive thyroid (hyperthyroidism). Stomach spasms. Parkinson s disease. 1 2 3 Get the ISOPTO * CARPINE bottle and a mirror. Wash your hands. Twist off the bottle cap. After cap is removed: if security collar is loose, remove before using product. Hold the bottle, pointing down, between your thumb and fingers. Tilt your head back. Pull down your lower eyelid with a clean finger until there is a pocket between the eyelid and your eye. The drop will go in here (picture 1). Bring the bottle tip close to the eye. Do this in front of a mirror if it helps. Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops. 131-ISOPTO CARPINE Prescribing Information non-annotated Page 11 of 12

IMPORTANT: PLEASE READ Gently press on the base of the bottle to release one drop of ISOPTO * CARPINE at a time. Do not squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs (picture 2). After using ISOPTO * CARPINE, press a finger into the corner of your eye, by the nose (picture 3). This helps to stop ISOPTO * CARPINE getting into the rest of the body. If a drop misses your eye, try again. If you use drops in both eyes, repeat the steps for your other eye. Close the bottle cap firmly immediately after use. Wash your hands after use. If you are using other eye medicines, wait at least 5-10 minutes between applying ISOPTO * CARPINE and the other drops. Eye ointments should be applied last. Overdose: If you use more ISOPTO * CARPINE than you should, rinse it all out with warm water. Do not put in any more drops until it is time for you next regular dose. Symptoms of an overdose may include: headache, salivating, sweating, fainting, slow heart rate, low blood pressure, stomach cramps, vomiting, asthma or diarrhea. In severe cases of an overdose, a doctor may need to treat you with another drug known as an anticholinergic. In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms. Missed Dose: If you forget to use ISOPTO * CARPINE, use a single dose as soon as you remember. If it is almost time for the next dose, leave out the missed dose and continue with the next dose of your regular routine. Do not use a double dose to make up for a missed dose. SIDE EFFECTS AND WHAT TO DO ABOUT THEM Like all medicines, ISOPTO * CARPINE may cause side effects, although not everybody gets them. closed when not in use. Keep out of the reach and sight of children. REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways: -------------------------------------------------------------------------- $ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345 $ Complete a Canada Vigilance Reporting Form and: - Fax toll-free to 1-866-678-6789, or - Mail to: Canada Vigilance Program Health Canada Postal Locator 0701D Ottawa, Ontario K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect Canada Web site at www.healthcanada.gc.ca/medeffect. NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice. MORE INFORMATION This document plus the full Prescribing Information, prepared for health professionals can be found at: http://www.alcon.ca or by contacting the sponsor, Alcon Canada Inc. at: 1-800-613-2245 This leaflet was prepared by Alcon Canada Inc. Last revised: January 25, 2016 2015 Novartis * a trademark of Novartis Side effects seen with ISOPTO * CARPINE include: blurred, reduced or abnormal vision, eye pain, eye irritation, eye redness, spots in your field of vision, retinal tear, bleeding inside the eye, eyelid swelling, decrease in pupil size, glare, abnormal sensation in the eye, increased eye pressure, eye swelling, headache, dizziness, nausea, and vomiting. This is not a complete list of side effects. For any unexpected effects while taking ISOPTO * CARPINE, contact your doctor or pharmacist. HOW TO STORE IT Store at room temperature. Avoid excessive heat. Keep tightly 131-ISOPTO CARPINE Prescribing Information non- annotated Page 12 of 12